| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10732134 | Physica Medica | 2015 | 8 Pages |
Abstract
The models and dose levels derived can be used in differential diagnosis of tumor recurrence from RRLI in patients treated with RT. Cross validation is needed to prove prediction performance of the model outside the dataset from which it was derived.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
M. Avanzo, M. Trovo, C. Furlan, L. Barresi, A. Linda, J. Stancanello, L. Andreon, E. Minatel, M. Bazzocchi, M.G. Trovo, E. Capra,